Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Blum

Showing results (241-250 of 291) with videos related to

Pageof 30
Sort By:
Epilepsia|July 14, 2022
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 yearsJacqueline A French, Elena Cleary, Dennis Dlugos, et al.
Brain : a Journal of Neurology|November 13, 2020
Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 miceLaetitia Degiorgis, Meltem Karatas, Marion Sourty, et al.
Brain : a Journal of Neurology|September 13, 2023
Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathologyIain J Hartnell, Declan Woodhouse, William Jasper, et al.
Neurobiology of Disease|January 15, 2005
Minocycline in phenotypic models of Huntington's diseaseKadiombo Bantubungi, Carine Jacquard, Anita Greco, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 8, 2011
Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoringRichard J E Skipworth, Guro B Stene, Max Dahele, et al.
Archives of Toxicology|January 25, 2018
Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulationCyrille Vandenbussche, Cynthia Van der Hauwaert, Edmone Dewaeles, et al.
Neurobiology of Disease|May 21, 2021
THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiencyAudrey Vautheny, Charlotte Duwat, Gwennaëlle Aurégan, et al.
Molecular Neurobiology|April 5, 2018
Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's DiseaseChia-Chia Lee, Ching-Pang Chang, Chun-Jung Lin, et al.
Praxis|August 21, 2024
[Can we learn to die?]Annina Seiler, Caroline Hertler, Sophia Rose Evstigneev, et al.
Acta Neuropathologica|June 3, 2026
AETA peptide contributes to Alzheimer's disease signature of synapse dysfunctionJade Dunot, Carine Gandin, Marin Truchi, et al.
Pageof 30

Showing results (241-250 of 291) with videos related to

Sort By:
Pageof 30
Epilepsia|July 14, 2022
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 yearsJacqueline A French, Elena Cleary, Dennis Dlugos, et al.
Brain : a Journal of Neurology|November 13, 2020
Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 miceLaetitia Degiorgis, Meltem Karatas, Marion Sourty, et al.
Brain : a Journal of Neurology|September 13, 2023
Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathologyIain J Hartnell, Declan Woodhouse, William Jasper, et al.
Neurobiology of Disease|January 15, 2005
Minocycline in phenotypic models of Huntington's diseaseKadiombo Bantubungi, Carine Jacquard, Anita Greco, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 8, 2011
Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoringRichard J E Skipworth, Guro B Stene, Max Dahele, et al.
Archives of Toxicology|January 25, 2018
Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulationCyrille Vandenbussche, Cynthia Van der Hauwaert, Edmone Dewaeles, et al.
Neurobiology of Disease|May 21, 2021
THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiencyAudrey Vautheny, Charlotte Duwat, Gwennaëlle Aurégan, et al.
Molecular Neurobiology|April 5, 2018
Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's DiseaseChia-Chia Lee, Ching-Pang Chang, Chun-Jung Lin, et al.
Praxis|August 21, 2024
[Can we learn to die?]Annina Seiler, Caroline Hertler, Sophia Rose Evstigneev, et al.
Acta Neuropathologica|June 3, 2026
AETA peptide contributes to Alzheimer's disease signature of synapse dysfunctionJade Dunot, Carine Gandin, Marin Truchi, et al.
Pageof 30